BIOGEN INC's ticker is and the CUSIP is 09062X903. A total of 8 filers reported holding BIOGEN INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,967,310 | -10.1% | 31,000 | -0.3% | 0.01% | -12.5% |
Q2 2023 | $8,858,835 | -27.3% | 31,100 | -29.0% | 0.01% | -42.9% |
Q1 2023 | $12,177,714 | -65.7% | 43,800 | -65.9% | 0.01% | -74.5% |
Q4 2022 | $35,528,836 | -32.0% | 128,300 | -34.4% | 0.06% | -17.9% |
Q3 2022 | $52,225,000 | +249.8% | 195,600 | +167.2% | 0.07% | +219.0% |
Q2 2022 | $14,928,000 | +190.5% | 73,200 | +200.0% | 0.02% | +320.0% |
Q1 2022 | $5,139,000 | -77.8% | 24,400 | -74.7% | 0.01% | -73.7% |
Q4 2021 | $23,128,000 | -61.2% | 96,400 | -44.0% | 0.02% | -74.0% |
Q2 2021 | $59,593,000 | +218.4% | 172,100 | +157.2% | 0.07% | +170.4% |
Q1 2021 | $18,715,000 | -76.0% | 66,900 | -79.0% | 0.03% | -73.0% |
Q4 2020 | $77,963,000 | +349.8% | 318,400 | +421.1% | 0.10% | +257.1% |
Q3 2020 | $17,333,000 | -29.4% | 61,100 | -33.4% | 0.03% | -44.0% |
Q2 2020 | $24,534,000 | +123.5% | 91,700 | +164.3% | 0.05% | +117.4% |
Q1 2020 | $10,978,000 | -54.8% | 34,700 | -57.6% | 0.02% | -62.9% |
Q4 2019 | $24,273,000 | +90.6% | 81,800 | +49.5% | 0.06% | +59.0% |
Q3 2019 | $12,735,000 | -24.4% | 54,700 | -24.0% | 0.04% | -27.8% |
Q2 2019 | $16,839,000 | -63.6% | 72,000 | -63.2% | 0.05% | -67.5% |
Q1 2019 | $46,236,000 | +692.0% | 195,600 | +908.2% | 0.17% | +822.2% |
Q4 2018 | $5,838,000 | – | 19,400 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CLEAR STREET MARKETS LLC | 40 | $1,161,000 | 0.17% |
SABBY MANAGEMENT, LLC | 30 | $871,000 | 0.14% |
SIMPLEX TRADING, LLC | 638 | $18,516,000 | 0.07% |
GROUP ONE TRADING, L.P. | 17,900 | $5,195,000 | 0.04% |
SG Americas Securities, LLC | 40,700 | $658,000 | 0.01% |
Allianz Asset Management GmbH | 22,300 | $6,472,000 | 0.01% |
JPMORGAN CHASE & CO | 100,500 | $29,169,000 | 0.01% |